The effect of estrogen replacement therapy on cognitive function in women: A critical review of the literature

Journal of Clinical Epidemiology

Volumn 50, Issue 11, 1997, Pages 1249-1264

  Haskell, Sally G ^a,b   Richardson, Emily D ^a   Horwitz, Ralph I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Alzheimer's disease; Cognition; Dementia; Estrogen replacement therapy

Indexed keywords

ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; ESTROGEN THERAPY; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MEMORY; MENOPAUSE; META ANALYSIS; MOOD; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL;

EID: 0030856295     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(97)00169-8     Document Type: Review

References (58)

1. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1977; 4: 33-47.
2. Kopera H. Estrogens and psychic functions. Front Horm Res 1973; 2: 118-133.
3. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994; 140: 256-261.
4. Dohanich GP, Witcher JA, Weaver DR, Clemens LG. Alteration of muscarinic binding in specific brain areas following estrogen treatment. Brain Res 1982; 241: 347-350.
5. Luine VN, Khylchevskaya RI, McEwen BS. Effect of gonadal steroids on activities of monamine oxidase and choline acetylase in rat brain. Brain Res 1975; 86: 293-306.
6. Luine VN, McEwen BS. Sex differences in cholinergic enzymes of diagonal band nuclei in the rat pre-optic area. Neuroendocrinology 1983; 36: 475-482.
7. Gould E, Wooley C, Frankfurt M. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990; 10: 1286-1291.
8. McEwen BS, Coirini H, Danielsson A, Frankfurt M, Gould E, Mendelson S, et al. Steroid and thyroid hormones modulate a changing brain. J Steroid Biochem Mol Biol 1991; 40: 1-14.
9. Toran-Allerand CD, Miranda RC, Bentham WDL, Sohrabbi F, Brown TJ, Hochberg RB, MacLusky NJ. Estrogen receptors co-localize with low affinity nerve growth receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 1992; 89: 4668-4672.
10. Komenich P, Lane DM, Dickey RP. Gonadal hormones and cognitive performance. Physiol Psychol 1978; 12: 1016-1037.
11. Wickham M. The effects of the menstrual cycle on test performance. Br J Psychol 1958; 49: 34-41.
12. Hampson E. Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cogn 1990; 14: 26-43.
13. Broverman DM, Vogel W, Klaiber EL. Changes in cognitive task performance across the menstrual cycle. J Comp Physiol Psychol 1981; 95: 646-654.
14. Sanders B, Soares MD, D'Aquila JM. The sex difference on one test of spatial visualization: A non-trivial difference. Child Dev 1982; 53: 1106-1110.
15. Kimura, D. Sex differences in the brain. Scientific American 1992; 267(3): 119-125.
16. Rocca WA, Amaducci LA, Schoenberg B. Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol 1986; 19: 415-424.
17. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr Scand 1987; 76: 465-479.
18. Hofman A, Rocca WA, Brayne C, Breteler MM, Clarke M, Cooper B, et al. The prevalence of dementia in Europe: A collaborative study of 1980-1990 findings. Int J Epidemiol 1991; 20: 736-748.
19. Kokmen E, Chandra V, Schoenberg BS. Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974. Neurology 1988; 38: 975-980.
20. Schoenberg BS, Kokmen E, Dkazaki H. Alzheimer's disease and other dementing illnesses in a defined US population: Incidence rates and clinical features. Ann Neurol 1987; 22: 724-729.
21. Hagnell O, Ojesjo L, Rorsman B. Incidence of dementia in the Lundby Study. Neuroepidemiology 1992; 11: 61-66.
22. Backman DL, Wolf PA, Linn RT, Kroefel JE, Cobb JL, Belanger AJ, et al. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham study. Neurology 1993; 43: 515-519.
23. Treves T, Korczyn AD, Zilber N. Presenile dementia in Israel. Arch Neurol 1986; 43: 26-29.
24. Nilsson LV. Incidence of senile dementia in an urban sample followed from 70-79 years of age. Acta Psychiatr Scand 1984; 70: 478-486.
25. Aronson MK, Ooi WL, Morgenstern H. Women, myocardial infarction, and dementia in the very old. Neurology 1990; 40: 1102-1106.
26. Grady D, Rubin S, Petitti D. Hormone therapy to prevent disease and prolong life in post-menopausal women. Ann Intern Med 1992; 117: 1016-1037.
27. Michael CM, Kantor HI. Further psychometric evaluation of older women: The effect of estrogen administration. J Gerontol 1970; 25: 337-341.
28. Furuhjelm M, Fedor-Freybergh P. The influence of estrogen on the psyche in climacteric and post-menopausal women. In: Vankeep PA, Greenblatt RB, Albeanx-Feurnet MM, Eds. Consensus on Menopausal Research. Baltimore, MD: University Park Press; 1976; 84-93.
29. Rauramo L, Lagerspetz K, Engblom P. The effect of castration and per oral estrogen therapy on some psychological functions. Front Horm Res 1975; 3: 94-104.
30. Vanhulle G, Demol R. A double blind study into the influence of estriol on a number of psychological tests in post-menopausal women. In: Vankeep PA, Greenblatt RB, Albeaux-Feurnet MM, Eds. Consensus on Menopausal Research. Baltimore, MD: University Park Press; 1976: 94-99.
31. Hackman BW, Galbraith D. Replacement therapy with piperazine oestrone sulfate (Harmogen) and its effects on memory. Curr Med Res Opin 1976; 4: 303-306.
32. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988; 13: 345-347.
33. Ditkoff EC, Crary WG, Cristo M. Estrogen improves psychological function in asymptomatic post-menopausal women. Obstet Gynecol 1991; 78: 991-995.
34. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992; 17: 485-495.
35. Honjo H, Ogino, Y, Naitoh K. In vivo effects by estrone sulfate on the central nervous system in senile dementia (Alzheimer's type). J Steroid Biochem 1989; 34: 521-525.
36. Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy post-menopausal women. Obstet Gynecol 1994; 83: 979-983.
37. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269: 2637-2641.
38. Henderson VW, Paganini-Hill A, Emanuel C. Estrogen replacement therapy in older women. Arch Neurol 1994; 51: 896-900.
39. Mortel KF, Meyer JS. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci 1995; 7: 334-337.
40. Brenner DE, Kukull WA, Stergachis A, van Belle G, Bowen JD, McCormick WC, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population based case-control study. Am J Epidemiol 1994; 140: 262-267.
41. Tang M-X, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348: 429-432.
42. Fillit H, Weinreb H, Cholst I, Luine V, McEwen B, Amador R, Zabriskie J. Observations in a preliminary open trial of estradiol therapy for senile dementia of the Alzheimer's type. Psychoneuroendocrinology 1986; 11: 337-345.
43. Ohkura T, Isse K, Alazawa K. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: Seven case reports. Dementia 1995; 6: 99-107.
44. Lezak MD. Neuropsychological Assessment, 3rd Edition. New York: Oxford; 1995.
45. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1995; 23: 56-62.
46. Eysenck HJ, Eysenck SBG. Eysenck Personality Inventory. San Diego, CA: Educational and Industrial Testing Service; 1968.
47. Hathaway SR, McKinley JC. Minnesota Multiphasic Personality Inventory. New York: The Psychological Corporation; 1943.
48. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York: Guilford Press; 1979.
49. Wechsler D. Manual for the Wechsler Adult Intelligence Scale. New York: The Psychological Corporation; 1955.
50. Benton AL. Revised Visual Retention Test, 4th Edition. San Antonio, TX: The Psychological Corporation; 1974.
51. Gilbert JG, Levee RS, Catalano FL. Guild Memory Test Manual. Newark, NJ: Unico National Mental Health Research Center; 1973.
52. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945; 19: 87-95.
53. Hasegawa K, Inoue K, Moriga K. An investigation of dementia rating scale for the elderly. Clin Psychiatry 1974; 16: 965-969.
54. Otsuka T, Shimonaka Y, Maruyama S, Nakazato K, Kitamura T, Yaguchi K, Sato S, Ikeda H. A new screening test for dementia. Jpn Psychiatry Neurol 1988; 42: 223-229.
55. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
56. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry 1968; 114: 797-811.
57. Mattis S. Dementia Rating Scale. Odessa: Psychological Assessment Resources; 1988.
58. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974; 24: 1019-1025.